Shahzad Malik Insider Trading $ARAV Aravive, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Shahzad Malik.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shahzad Malik. Shahzad Malik is Director in AGENUS INC ($AGEN) and Director in Conatus Pharmaceuticals Inc. ($CNAT) and Director in Versartis, Inc. ($VSAR) and Director in Acutus Medical, Inc. ($AFIB) and Director in Axonics Modulation Technologies, Inc. ($AXNX) and Director in Iterum Therapeutics plc ($ITRM).
Shahzad Malik in Aravive, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Shahzad Malik: Director
Holdings: 23,880 shares
Current Value: $317,604
Latest Transaction: Sep 13 2019
$ARAV Market Capitalization: $474.95M
$ARAV Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Shahzad Malik in Aravive, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AFIB, AGEN, ARAV, AXNX, HSTO, ITRM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 13 2019 | ARAV | Aravive, Inc. | Malik Shahzad | Director | Option Exercise | A | 5.77 | 7,500 | 43,275 | 7,500 | |
| Jan 07 2019 | VSAR | Aravive, Inc. | Malik Shahzad | Director | Option Exercise | A | 3.69 | 4,688 | 17,299 | 4,688 | |
| Dec 22 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Grant | A | 0.00 | 11,200 | 0 | 23,880 | 12.7 K to 23.9 K (+88.33 %) |
| Jun 06 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Option Exercise | A | 15.83 | 6,850 | 108,401 | 6,850 | |
| Jun 06 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Grant | A | 0.00 | 3,480 | 0 | 12,680 | 9.2 K to 12.7 K (+37.83 %) |
| Mar 17 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Sell | S | 18.01 | 386,367 | 6,958,470 | 1,621,558 | 2 M to 1.6 M (-19.24 %) |
| Mar 17 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Sell | S | 18.50 | 97,303 | 1,800,106 | 2,007,925 | 2.1 M to 2 M (-4.62 %) |
| Mar 15 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Sell | S | 19.08 | 103,122 | 1,967,568 | 2,105,228 | 2.2 M to 2.1 M (-4.67 %) |
| Mar 15 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Sell | S | 19.00 | 46,778 | 888,782 | 2,208,350 | 2.3 M to 2.2 M (-2.07 %) |
| Mar 15 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Sell | S | 19.03 | 100 | 1,903 | 2,255,128 | 2.3 M to 2.3 M (0.00 %) |
| Mar 15 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Sell | S | 19.42 | 16,330 | 317,129 | 2,255,228 | 2.3 M to 2.3 M (-0.72 %) |
| May 20 2016 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Option Exercise | A | 8.12 | 14,625 | 118,755 | 14,625 | |
| May 20 2016 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Grant | A | 0.00 | 4,625 | 0 | 9,200 | 4.6 K to 9.2 K (+101.09 %) |
| Jul 01 2015 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Option Exercise | A | 14.73 | 13,100 | 192,963 | 13,100 | |
| Jul 01 2015 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Grant | A | 0.00 | 4,575 | 0 | 4,575 | 0 to 4.6 K |
Page: 1